What one share of Korro Bio holds
We are a biopharmaceutical company with a mission to discover, develop and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. We are generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient change to a single nucleoside (adenosine to an inosine edit).
Korro Bio’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.20 |
|---|---|
| Profit | −$8.89 |
| Capex (buildings and equipment) | $0.03 |
| Free cash flow | −$5.69 |
| Cash and investments | $9.38 |
| Book value | $7.02 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $0.00 | −$227.42 | $20.13 | −$230.36 | — | −$368.87 |
| 2023 | $0.00 | −$53.08 | $5.12 | −$49.12 | — | — |
| 2024 | $0.25 | −$9.37 | $2.01 | −$8.74 | — | $17.11 |
| 2025 | $0.68 | −$12.48 | $0.06 | −$8.42 | — | $5.46 |
Common questions about Korro Bio
How much does one share of Korro Bio earn?
Over the last 12 months, Korro Bio lost $8.89 for each share on $0.20 of sales.
Does Korro Bio pay a dividend?
Korro Bio didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Korro Bio’s book value per share?
Korro Bio’s book value is $7.02 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Korro Bio have?
Each share of Korro Bio has $9.38 of cash and investments, as of June 30, 2026.
What is Korro Bio’s free cash flow per share?
−$5.69 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Korro Bio bought back shares?
Korro Bio’s share count rose about 3582% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.